Spire Healthcare Group PLC (LON:SPI) has been assigned a consensus recommendation of “Hold” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is GBX 132 ($1.72).
Several brokerages have recently issued reports on SPI. Numis Securities restated a “buy” rating and issued a GBX 163 ($2.13) price objective on shares of Spire Healthcare Group in a research note on Thursday, February 28th. JPMorgan Chase & Co. restated a “neutral” rating on shares of Spire Healthcare Group in a research note on Wednesday, January 16th. Credit Suisse Group lowered their price objective on shares of Spire Healthcare Group from GBX 85 ($1.11) to GBX 75 ($0.98) and set an “underperform” rating on the stock in a research note on Wednesday, March 13th. Peel Hunt lowered their price objective on shares of Spire Healthcare Group from GBX 175 ($2.29) to GBX 155 ($2.03) and set a “hold” rating on the stock in a research note on Thursday, February 28th. Finally, Liberum Capital restated a “hold” rating and issued a GBX 115 ($1.50) price objective (down previously from GBX 176 ($2.30)) on shares of Spire Healthcare Group in a research note on Tuesday, January 15th.
Shares of Spire Healthcare Group stock traded down GBX 2.10 ($0.03) during midday trading on Thursday, hitting GBX 128 ($1.67). The company had a trading volume of 900,843 shares, compared to its average volume of 1,770,000. The company has a market cap of $513.38 million and a price-to-earnings ratio of 45.71. The company has a current ratio of 1.44, a quick ratio of 0.95 and a debt-to-equity ratio of 48.52. Spire Healthcare Group has a 1-year low of GBX 96.15 ($1.26) and a 1-year high of GBX 259.20 ($3.39).
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading: NASDAQ Stock Market Explained
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.